Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE? [Yahoo! Finance]
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Morgan Stanley from $100.00 to $102.00. They now have an "equal weight" rating on the stock.
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
Merck & Co., (MRK) Gets Conditional Approval For EXZOLT CATTLE-CA1 [Yahoo! Finance]
Guggenheim Lifts PT on Merck & Co. (MRK) to $122 From $104 [Yahoo! Finance]